Poseida Therapeutics Stock Market Value
| PSTX Stock | USD 9.33 0.05 0.53% |
| Symbol | Poseida |
Poseida Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Poseida Therapeutics. If investors know Poseida will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Poseida Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 1.564 | Quarterly Revenue Growth 6.672 | Return On Assets (0.13) | Return On Equity (0.58) |
The market value of Poseida Therapeutics is measured differently than its book value, which is the value of Poseida that is recorded on the company's balance sheet. Investors also form their own opinion of Poseida Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Poseida Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Poseida Therapeutics' market value can be influenced by many factors that don't directly affect Poseida Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Poseida Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Poseida Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Poseida Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Poseida Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Poseida Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Poseida Therapeutics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Poseida Therapeutics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Poseida Therapeutics or generate 0.0% return on investment in Poseida Therapeutics over 30 days. Poseida Therapeutics is related to or competes with Molecular Partners, Mineralys Therapeutics,, AN2 Therapeutics, Pharvaris, PepGen, Century Therapeutics, and Passage Bio. Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients ... More
Poseida Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Poseida Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Poseida Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.36 | |||
| Information Ratio | 0.1215 | |||
| Maximum Drawdown | 34.47 | |||
| Value At Risk | (6.65) | |||
| Potential Upside | 5.47 |
Poseida Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Poseida Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Poseida Therapeutics' standard deviation. In reality, there are many statistical measures that can use Poseida Therapeutics historical prices to predict the future Poseida Therapeutics' volatility.| Risk Adjusted Performance | 0.1062 | |||
| Jensen Alpha | 3.25 | |||
| Total Risk Alpha | (0.71) | |||
| Sortino Ratio | 0.7928 | |||
| Treynor Ratio | 1.28 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Poseida Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Poseida Therapeutics Backtested Returns
Poseida Therapeutics is dangerous given 3 months investment horizon. Poseida Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.72% are justified by taking the suggested risk. Use Poseida Therapeutics Coefficient Of Variation of 794.08, semi deviation of 3.07, and Risk Adjusted Performance of 0.1062 to evaluate company specific risk that cannot be diversified away. Poseida Therapeutics holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of 2.78, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Poseida Therapeutics will likely underperform. Use Poseida Therapeutics skewness, day typical price, and the relationship between the downside variance and daily balance of power , to analyze future returns on Poseida Therapeutics.
Auto-correlation | 0.86 |
Very good predictability
Poseida Therapeutics has very good predictability. Overlapping area represents the amount of predictability between Poseida Therapeutics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Poseida Therapeutics price movement. The serial correlation of 0.86 indicates that approximately 86.0% of current Poseida Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.86 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 7.93 |
Poseida Therapeutics lagged returns against current returns
Autocorrelation, which is Poseida Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Poseida Therapeutics' stock expected returns. We can calculate the autocorrelation of Poseida Therapeutics returns to help us make a trade decision. For example, suppose you find that Poseida Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Poseida Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Poseida Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Poseida Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Poseida Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Poseida Therapeutics Lagged Returns
When evaluating Poseida Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Poseida Therapeutics stock have on its future price. Poseida Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Poseida Therapeutics autocorrelation shows the relationship between Poseida Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Poseida Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Poseida Stock Analysis
When running Poseida Therapeutics' price analysis, check to measure Poseida Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poseida Therapeutics is operating at the current time. Most of Poseida Therapeutics' value examination focuses on studying past and present price action to predict the probability of Poseida Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poseida Therapeutics' price. Additionally, you may evaluate how the addition of Poseida Therapeutics to your portfolios can decrease your overall portfolio volatility.